{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:50:14Z","timestamp":1791222614426,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biomed Eng"],"DOI":"10.1038\/s41551-020-00642-4","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T07:02:54Z","timestamp":1603954974000},"page":"1188-1196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8541-5752","authenticated-orcid":false,"given":"Tiancheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hsiung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Sreedhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl V.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6707-1597","authenticated-orcid":false,"given":"Kjerstie","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Keare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Bliden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Gurbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya S.","family":"Tantry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Boggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge P.","family":"Rodriguez-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3378-8071","authenticated-orcid":false,"given":"Jose G.","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3432-4479","authenticated-orcid":false,"given":"Meijie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-4502","authenticated-orcid":false,"given":"Hongjie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"key":"642_CR1","doi-asserted-by":"publisher","unstructured":"Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.3.2000045 (2020).","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"642_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/14737159.2020.1757437","volume":"20","author":"A Tahamtan","year":"2020","unstructured":"Tahamtan, A. & Ardebili, A. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev. Mol. Diagn. 20, 453\u2013454 (2020).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"642_CR3","doi-asserted-by":"publisher","unstructured":"Kashir, J. & Yaqinuddin, A. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19. Med. Hypotheses https:\/\/doi.org\/10.1016\/j.mehy.2020.109786 (2020).","DOI":"10.1016\/j.mehy.2020.109786"},{"key":"642_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/clinchem\/hvaa102","volume":"66","author":"L Yu","year":"2020","unstructured":"Yu, L. et al. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform. Clin. Chem. 66, 975\u2013977 (2020).","journal-title":"Clin. Chem."},{"key":"642_CR5","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S0140-6736(20)30788-1","volume":"395","author":"A Petherick","year":"2020","unstructured":"Petherick, A. Developing antibody tests for SARS-CoV-2. Lancet 395, 1101\u20131102 (2020).","journal-title":"Lancet"},{"key":"642_CR6","doi-asserted-by":"publisher","unstructured":"Vashist, S. K. In vitro diagnostic assays for COVID-19: recent advances and emerging trends. Diagnostics https:\/\/doi.org\/10.3390\/diagnostics10040202 (2020).","DOI":"10.3390\/diagnostics10040202"},{"key":"642_CR7","doi-asserted-by":"publisher","unstructured":"Younes, N. et al. Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2. Viruses https:\/\/doi.org\/10.3390\/v12060582 (2020).","DOI":"10.3390\/v12060582"},{"key":"642_CR8","doi-asserted-by":"publisher","unstructured":"Montesinos, I. et al. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. J. Clin. Virol. https:\/\/doi.org\/10.1016\/j.jcv.2020.104413 (2020).","DOI":"10.1016\/j.jcv.2020.104413"},{"key":"642_CR9","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1515\/cclm-2020-0594","volume":"58","author":"M Tre-Hardy","year":"2020","unstructured":"Tre-Hardy, M. et al. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody. Clin. Chem. Lab. Med. 58, 1357\u20131364 (2020).","journal-title":"Clin. Chem. Lab. Med."},{"key":"642_CR10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","volume":"26","author":"F Amanat","year":"2020","unstructured":"Amanat, F. et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med. 26, 1033\u20131036 (2020).","journal-title":"Nat. Med."},{"key":"642_CR11","doi-asserted-by":"publisher","unstructured":"Lassauni\u00e8re, R. et al. Evaluation of nine commercial SARS-CoV-2 immunoassays. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.04.09.20056325 (2020).","DOI":"10.1101\/2020.04.09.20056325"},{"key":"642_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.12688\/wellcomeopenres.15927.1","volume":"5","author":"ER Adams","year":"2020","unstructured":"Adams, E. R. et al. Antibody testing for COVID-19: a report from the National COVID Scientific Advisory Panel. Wellcome Open Res 5, 139 (2020).","journal-title":"Wellcome Open Res"},{"key":"642_CR13","doi-asserted-by":"publisher","unstructured":"Zhao, J. et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa344 (2020).","DOI":"10.1093\/cid\/ciaa344"},{"key":"642_CR14","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3201\/eid2607.200841","volume":"26","author":"NMA Okba","year":"2020","unstructured":"Okba, N. M. A. et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg. Infect. Dis. 26, 1478\u20131488 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"642_CR15","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/jmv.25932","volume":"92","author":"M Infantino","year":"2020","unstructured":"Infantino, M. et al. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience. J. Med. Virol. 92, 1671\u20131675 (2020).","journal-title":"J. Med. Virol."},{"key":"642_CR16","doi-asserted-by":"publisher","unstructured":"Theel, E. S., Harring, J., Hilgart, H. & Granger, D. Performance characteristics of four high-throughput immunoassays for detection of IgG antibodies against SARS-CoV-2. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/jcm.01243-20 (2020).","DOI":"10.1128\/jcm.01243-20"},{"key":"642_CR17","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/clinchem\/hvaa132","volume":"66","author":"MS Tang","year":"2020","unstructured":"Tang, M. S. et al. Clinical performance of the Roche SARS-CoV-2 serologic assay. Clin. Chem. 66, 1107\u20131109 (2020).","journal-title":"Clin. Chem."},{"key":"642_CR18","doi-asserted-by":"publisher","unstructured":"Bendavid, E. et al. COVID-19 antibody seroprevalence in Santa Clara County, California. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.04.14.20062463 (2020).","DOI":"10.1101\/2020.04.14.20062463"},{"key":"642_CR19","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/s41591-020-0949-6","volume":"26","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat. Med. 26, 1193\u20131195 (2020).","journal-title":"Nat. Med."},{"key":"642_CR20","doi-asserted-by":"publisher","unstructured":"Reifer, J., Hayum, N., Heszkel, B., Klagsbald, I. & Streva, V. A. SARS-CoV-2 IgG antibody responses in New York City. Diagn. Microbiol. Infect. Dis. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115128 (2020).","DOI":"10.1016\/j.diagmicrobio.2020.115128"},{"key":"642_CR21","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1001\/jama.2020.8279","volume":"323","author":"N Sood","year":"2020","unstructured":"Sood, N. et al. Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los Angeles County, California, on April 10\u201311, 2020. JAMA 323, 2425\u20132427 (2020).","journal-title":"JAMA"},{"key":"642_CR22","doi-asserted-by":"publisher","unstructured":"Levesque, J. & Maybury, D. W. A note on COVID-19 seroprevalence studies: a meta-analysis using hierarchical modelling. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.05.03.20089201 (2020).","DOI":"10.1101\/2020.05.03.20089201"},{"key":"642_CR23","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/clinchem\/hvaa120","volume":"66","author":"MS Tang","year":"2020","unstructured":"Tang, M. S. et al. Clinical performance of two SARS-CoV-2 serologic assays. Clin. Chem. 66, 1055\u20131062 (2020).","journal-title":"Clin. Chem."},{"key":"642_CR24","doi-asserted-by":"publisher","unstructured":"Bauer, G. The variability of the serological response to SARS-corona virus-2: potential resolution of ambiguity through determination of avidity (functional affinity). J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.26262 (2020).","DOI":"10.1002\/jmv.26262"},{"key":"642_CR25","first-page":"113","volume":"87","author":"J Gutierrez","year":"1996","unstructured":"Gutierrez, J. & Maroto, C. Are IgG antibody avidity assays useful in the diagnosis of infectious diseases? A review. Microbios 87, 113\u2013121 (1996).","journal-title":"Microbios"},{"key":"642_CR26","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1128\/JCM.40.11.4015-4020.2002","volume":"40","author":"B Suligoi","year":"2002","unstructured":"Suligoi, B. et al. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J. Clin. Microbiol. 40, 4015\u20134020 (2002).","journal-title":"J. Clin. Microbiol."},{"key":"642_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1086\/341831","volume":"186","author":"MG Revello","year":"2002","unstructured":"Revello, M. G. et al. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J. Infect. Dis. 186, 553\u2013557 (2002).","journal-title":"J. Infect. Dis."},{"key":"642_CR28","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1128\/JCM.42.4.1782-1784.2004","volume":"42","author":"VAUF De Souza","year":"2004","unstructured":"De Souza, V. A. U. F. et al. Use of an immunoglobulin G avidity test to discriminate between primary and secondary Dengue virus infections. J. Clin. Microbiol. 42, 1782\u20131784 (2004).","journal-title":"J. Clin. Microbiol."},{"key":"642_CR29","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm.4302","volume":"23","author":"B Zhang","year":"2017","unstructured":"Zhang, B. et al. Diagnosis of Zika virus infection on a nanotechnology platform. Nat. Med. 23, 548\u2013550 (2017).","journal-title":"Nat. Med."},{"key":"642_CR30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/BF00917569","volume":"8","author":"K Hedman","year":"1988","unstructured":"Hedman, K. & Seppala, I. Recent rubella virus infection indicated by a low avidity of specific IgG. J. Clin. Immunol. 8, 214\u2013221 (1988).","journal-title":"J. Clin. Immunol."},{"key":"642_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1477","volume":"2","author":"SM Tabakman","year":"2011","unstructured":"Tabakman, S. M. et al. Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range. Nat. Commun. 2, 466 (2011).","journal-title":"Nat. Commun."},{"key":"642_CR32","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/nm.3619","volume":"20","author":"B Zhang","year":"2014","unstructured":"Zhang, B., Kumar, R. B., Dai, H. & Feldman, B. J. A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes. Nat. Med. 20, 948\u2013953 (2014).","journal-title":"Nat. Med."},{"key":"642_CR33","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1128\/JCM.03371-15","volume":"54","author":"X Li","year":"2016","unstructured":"Li, X. et al. Multiplexed anti-toxoplasma IgG, IgM and IgA assay on plasmonic gold chips: towards making mass screening possible with dye test precision. J. Clin. Microbiol. 54, 1726\u20131733 (2016).","journal-title":"J. Clin. Microbiol."},{"key":"642_CR34","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s10096-019-03487-1","volume":"38","author":"X Li","year":"2019","unstructured":"Li, X. et al. Plasmonic gold chips for the diagnosis of Toxoplasma gondii, CMV and rubella infections using saliva with serum detection precision. Eur. J. Clin. Microbiol. Infect. Dis. 38, 883\u2013890 (2019).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"642_CR35","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/hep.28957","volume":"66","author":"X Chen","year":"2017","unstructured":"Chen, X. et al. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected Mongolians. Hepatology 66, 1739\u20131749 (2017).","journal-title":"Hepatology"},{"key":"642_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292 (2020).","journal-title":"Cell"},{"key":"642_CR37","doi-asserted-by":"publisher","unstructured":"Liu, W. et al. Evaluation of nucleocapsid and spike protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/jcm.00461-20 (2020).","DOI":"10.1128\/jcm.00461-20"},{"key":"642_CR38","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"Q-X Long","year":"2020","unstructured":"Long, Q.-X. et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 26, 845\u2013848 (2020).","journal-title":"Nat. Med."},{"key":"642_CR39","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444\u20131448 (2020).","journal-title":"Science"},{"key":"642_CR40","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.chom.2020.04.023","volume":"27","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Identification of human single-domain antibodies against SARS-CoV-2. Cell Host Microbe 27, 891\u2013898 (2020).","journal-title":"Cell Host Microbe"},{"key":"642_CR41","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1126\/science.abb7269","volume":"368","author":"M Yuan","year":"2020","unstructured":"Yuan, M. et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science 368, 630\u2013633 (2020).","journal-title":"Science"},{"key":"642_CR42","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1128\/CVI.05278-11","volume":"18","author":"HE Prince","year":"2011","unstructured":"Prince, H. E., Yeh, C. & Lap\u00e9-Nixon, M. Utility of IgM\/IgG ratio and IgG avidity for distinguishing primary and secondary Dengue virus infections using sera collected more than 30 days after disease onset. Clin. Vaccin. Immunol. 18, 1951\u20131956 (2011).","journal-title":"Clin. Vaccin. Immunol."},{"key":"642_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290\u2013295 (2020).","journal-title":"Nature"},{"key":"642_CR44","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1080\/22221751.2020.1780951","volume":"9","author":"WN Chia","year":"2020","unstructured":"Chia, W. N. et al. Serological differentiation between COVID-19 and SARS infections. Emerg. Microbes Infect. 9, 1497\u20131505 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"642_CR45","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","volume":"30","author":"GD Victora","year":"2012","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 30, 429\u2013457 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"642_CR46","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1128\/IAI.67.5.2366-2370.1999","volume":"67","author":"WR Usinger","year":"1999","unstructured":"Usinger, W. R. & Lucas, A. H. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides. Infect. Immun. 67, 2366\u20132370 (1999).","journal-title":"Infect. Immun."},{"key":"642_CR47","doi-asserted-by":"crossref","unstructured":"Doba\u00f1o, C. et al. Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S\/AS01E malaria vaccine efficacy. Nat. Commun. 10, 2174 (2019).","DOI":"10.1038\/s41467-019-10195-z"},{"key":"642_CR48","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/d41587-020-00011-1","volume":"38","author":"C Sheridan","year":"2020","unstructured":"Sheridan, C. Convalescent serum lines up as first-choice treatment for coronavirus. Nat. Biotechnol. 38, 655\u2013658 (2020).","journal-title":"Nat. Biotechnol."},{"key":"642_CR49","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1128\/CVI.00056-07","volume":"14","author":"KH Chan","year":"2007","unstructured":"Chan, K. H. et al. Use of antibody avidity assays for diagnosis of severe acute respiratory syndrome coronavirus infection. Clin. Vaccin. Immunol. 14, 1433\u20131436 (2007).","journal-title":"Clin. Vaccin. Immunol."},{"key":"642_CR50","doi-asserted-by":"publisher","unstructured":"Yaqinuddin, A. Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities. Med. Hypotheses https:\/\/doi.org\/10.1016\/j.mehy.2020.110049 (2020).","DOI":"10.1016\/j.mehy.2020.110049"},{"key":"642_CR51","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1042\/CS20180874","volume":"133","author":"AKM Furuya","year":"2019","unstructured":"Furuya, A. K. M. et al. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past Dengue virus infections. Clin. Sci. 133, 859\u2013867 (2019).","journal-title":"Clin. Sci."},{"key":"642_CR52","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/infdis\/jiaa273","volume":"222","author":"PD Burbelo","year":"2020","unstructured":"Burbelo, P. D. et al. Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019. J. Infect. Dis. 222, 206\u2013213 (2020).","journal-title":"J. Infect. Dis."},{"key":"642_CR53","doi-asserted-by":"publisher","unstructured":"Bat\u00e9jat, C., Grassin, Q., Manuguerra, J.-C. & Leclercq, I. Heat inactivation of the severe acute respiratory syndrome coronavirus 2. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2020.05.01.067769 (2020).","DOI":"10.1101\/2020.05.01.067769"},{"key":"642_CR54","doi-asserted-by":"publisher","unstructured":"Wang, T., Lien, C., Liu, S. & Selveraj, P. Effective heat inactivation of SARS-CoV-2. Preprint at medXriv https:\/\/doi.org\/10.1101\/2020.04.29.20085498 (2020).","DOI":"10.1101\/2020.04.29.20085498"},{"key":"642_CR55","doi-asserted-by":"crossref","unstructured":"Liu, T. et al. Dataset for quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates (Figshare, 2020); https:\/\/doi.org\/10.6084\/m9.figshare.13011527","DOI":"10.1038\/s41551-020-00642-4"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-00642-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-00642-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-00642-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T22:58:20Z","timestamp":1670281100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-00642-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["642"],"URL":"https:\/\/doi.org\/10.1038\/s41551-020-00642-4","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,29]]},"assertion":[{"value":"8 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.D. worked on this project as a consultant for Nirmidas Biotech, independently of Stanford Projects. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}